Jin Chen
- Cellular and Molecular Neuroscience top 0.5%
- Axon Guidance and Neuronal Signaling 48
- Cancer Research top 0.5%
- Molecular Biology top 0.5%
- Angiogenesis and VEGF in Cancer 40
- RNA modifications and cancer 12
- Cell Biology top 0.5%
- Hippo pathway signaling and YAP/TAZ 23
- Oncology top 1%
- HER2/EGFR in Cancer Research 12
-
- Immunotherapy and Immune Responses 17
- Immune Cell Function and Interaction 14
-
- Cell Adhesion Molecules Research 16
- Co-authors
- Dana M. Brantley‐SiedersDana M. BrantleyYoonha HwangNikki ChengRebecca S. CookLaura C. KimGuanglei ZhuangH. Earl Ruley
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Jin Chen
335 papers receiving 13.9k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Cellular and Molecular Neuroscience 3.1k
- Cancer Research 1.8k
- Molecular Biology 8.1k
- Cell Biology 1.9k
- Oncology 2.6k
Countries citing papers authored by Jin Chen
This map shows the geographic impact of Jin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Chen more than expected).
Fields of papers citing papers by Jin Chen
This network shows the impact of papers produced by Jin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Chen. The network helps show where Jin Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 1 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 9 | |
| 12 | 2019 | 39 | |
| 13 | 2019 | 5 | |
| 14 | 2016 | 14 | |
| 15 | 2016 | 61 | |
| 16 | 2016 | 84 | |
| 17 | 2014 | 14 | |
| 18 | 2010 | 51 | |
| 19 | 2009 | 48 | |
| 20 | 2002 | 410 |
About Jin Chen
Jin Chen is a scholar working on Immunology and Allergy, Cellular and Molecular Neuroscience and Molecular Biology, having authored 354 papers that have together received 14.2k indexed citations. Recurring topics across this work include Axon Guidance and Neuronal Signaling (48 papers), Angiogenesis and VEGF in Cancer (40 papers), Hippo pathway signaling and YAP/TAZ (23 papers), Immunotherapy and Immune Responses (17 papers), Cell Adhesion Molecules Research (16 papers), Immune Cell Function and Interaction (14 papers), RNA modifications and cancer (12 papers) and HER2/EGFR in Cancer Research (12 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (3.1k citations), Cancer Research (1.8k citations) and Molecular Biology (8.1k citations). Jin Chen has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Dana M. Brantley‐Sieders, Dana M. Brantley, Yoonha Hwang, Nikki Cheng, Rebecca S. Cook, Laura C. Kim, Guanglei Zhuang, H. Earl Ruley, Wei Bin Fang and Donna J. Hicks. Their work appears in journals such as Cancer Research, PLoS ONE, Oncogene, IEEE Transactions on Nuclear Science and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.